A series of field studies using strain TC-83 attenuated Venezuelan equine encephalomyelitis vaccine in horses was made to determine the rate of seroconversions, the postvaccination viremia, and the possibility of adverse reactions to the vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The MATERIALS AND METHODS Vaccine. The strain TC-83 vaccine was supplied by USAMRDC in 100-dose vials of lyophilized virus. The diluent consisted of 10% human serum albumin in Hanks balanced salt solution in 50-ml vials. The dose of vaccine used was 0.5 ml of the reconstituted product given subcutaneously or intramuscularly within 4 hr of reconstitution. The vaccine used in study 1 was from lot SB and that in studies 2 and 3 was from lot 5.
vaccine. The rate of seroconversions varied from 50% in one study to 91 and 100% in two others. The (3, 6; T. E. Walton et al., Amer. J. Epidemiol, in press) and subsequently spread through Mexico and into the United States (5) . Control of the epizootic was attempted primarily through vaccination with the strain TC-83 attenuated VEE vaccine developed by the U.S. Army Medical Research and Development Command (USAMRDC) (1) . This report describes field studies of the vaccine in equines to assay immune responses, resulting viremia levels, and the occurrence of adverse reactions to the vaccine.
MATERIALS AND METHODS
Vaccine. The strain TC-83 vaccine was supplied by USAMRDC in 100-dose vials of lyophilized virus. The diluent consisted of 10% human serum albumin in Hanks balanced salt solution in 50-ml vials. The dose of vaccine used was 0.5 ml of the reconstituted product given subcutaneously or intramuscularly within 4 hr of reconstitution. The vaccine used in study 1 was from lot SB and that in studies 2 and 3 was from lot 5.
Antibody titration. Serum was assayed for virus neutralizing antibody by measuring plaque reduction by the method of Earley et al. (2) . The titrations were made in serial fourfold dilutions from 1:8 through 1:8,192; titers were recorded as the reciprocal of the highest dilution giving an 80% or greater reduction in plaque counts. In some cases, the sera were tested only at a 1:8 dilution for a reduction in plaque count of 80% or more. One or two virus strains were included in each Virus isolations. Sera from horses with a measurable viremia and selected sera from horses which showed encephalitic signs were inoculated into Vero cell monolayers or suckling mice for virus isolation and subsequent identification. From the known viremic sera, a previously unthawed portion was used to inoculate 0.2 ml of serum into each of four tubes of Vero cell culture. The resulting culture fluid was used as the virus pool. Selected sera from encephalitic horses were inoculated intracerebrally into suckling mice by using 0.02 ml of serum inoculum for each of eight mice. From the dead or moribund mice, a 10% brain suspension was prepared in phosphate-buffered saline solution (pH 7.3) with 0.5% gelatin.
Classification of viral isolates. Two methods were used to determine whether viruses isolated from the sera of vaccinated horses were vaccine virus or the epizootic agent. The serum isolates made in Vero cell culture or suckling mouse brain were each inoculated subcutaneously into five weanling mice by using 0. were typed by the KHI test. The mouse-virulent isolates developed a pattern similar to the epizootic I-B subtype. The avirulent isolates were distinct from the epizootic strain and similar to the strain TC-83 virus. The viremia patterns of horses that had mouse-virulent virus are shown in Table  2 . With one exception, the viremias attributable to epizootic virus commenced before the third day postvaccination.
The 26 horses retained in study 1 exhibited varying levels of viremia as shown in Table 3 . Measurable virus was detected in 10 horses. One of these horses was viremic for 3 consecutive days, whereas virus was detected in the sera of the nine others only once. The maximum titer was 7 X 103 to 8 X 103 PFU/ml at 39 hr postvaccination, and the second highest titer of 4 X 103 PFU/ml was found in a 111-hr serum. The virus content in the sera of the other horses ranged down to undetectable levels.
All of approximately 900 horses at the ranch in study 1 were vaccinated during a 2-day period in September 1970 in the midst of an epizootic. Approximately 30 deaths with encephalitis had occurred at the time of vaccination, and an additional 12 deaths occurred during the following 8 to 9 days. No horse deaths attributable to encephalitis occurred subsequent to 9 days postvaccination despite the persistence of the rainy season through October 1970.
None of the horses at the farm described in study 2 presented evidence of adverse reactions attributable to the vaccine. Most of the horses were valuable thoroughbred stock and were observed daily by Rodriguez-Martin. He found that approximately 10% of the horses exhibited a mild lassitude within 2 to 3 days postvaccination; fevers, when present, were in the range of 102 to 103 F. The farm also maintains thorough breeding records, and the mares are examined periodically for pregnancy. At the time of vaccination, there were 42 pregnant mares in various stages of gestation as follows: 3 at 1 to 2 months, 13 at 3 to 4 months, 23 at 5 to 6 months, and 3 at 7 months or more. In the period immediately after the vaccination, no abortions occured. However, one mare in the fifth month ofpregnancy at the time of vaccination aborted two months later, and a second mare aborted an 8-month fetus 6 months after vaccination. None of the other 40 mares aborted, nor were the resulting foals abnormal in any way. The farm has experienced a 3 to 4% abortion rate per year. Twelve of the 42 mares, including the two that aborted, were subsequently diagnosed as positive for equine infectious anemia by Leroy Coggins, Cornell University, on the basis of an immunodiffusion test for antibodies associated with that disease. Rodriguez-Martin has observed that abortions are not uncommon in mares afflicted with infectious anemia.
DISCUSSION
Because of the possibility that the vaccine virus may revert to virulence through successive horsemosquito-horse passages, the magnitude of the viremia resulting from vaccination is of great interest. Our data show that low levels of virus circulating in the blood of horses may be expected after vaccination. Henderson et al. (4) that no horses died of VEE prior to 5 days postinfection, and on the failure to observe the initiation of epizootic virus-induced viremias after 3 days postvaccination (Table 2) . Therefore, the cessation of horse deaths 8 to 9 days postvaccination in this and other studies (D. H. Martin et al., Amer. J. Epidemiol., In press) provided evidence for early protection by TC-83 vaccine.
Although adverse reactions, including abortions, have been reported to MARU staff members during the Central American vaccination programs, we saw no evidence of this. Fevers, when observed, did not exceed 102 to 103 F. The 42 pregnant mares showed no indication of vaccine-induced abortion, and the foals were normal. We have observed numerous large-scale horse vaccination programs in Central America where the animals have experienced rough handling. It is our opinion that the reported abortions, if true, are more likely to have been caused by the trauma received than by the vaccine.
